Evolus to Participate in Fireside Chats and One-on-One Meetings at Upcoming Investor Conferences
Evolus (NASDAQ: EOLS), a performance beauty company focused on building an aesthetic portfolio, has announced its upcoming participation in two major investor conferences in Miami, FL.
The company's management team will engage in fireside chats and investor meetings at:
- The Leerink Partners Global Biopharma Conference - Tuesday, March 11, 2025, at 9:20 AM ET
- The Barclays 27th Annual Global Healthcare Conference - Wednesday, March 12, 2025, at 3:30 PM ET
Both fireside chats will be accessible through the Investor Relations page on Evolus's website, with webcasts remaining available for 90 days following each presentation.
Evolus (NASDAQ: EOLS), un'azienda di bellezza performante focalizzata sulla costruzione di un portafoglio estetico, ha annunciato la sua prossima partecipazione a due importanti conferenze per investitori a Miami, FL.
Il team di gestione dell'azienda parteciperà a discussioni informali e incontri con gli investitori presso:
- La Conferenza Globale Biopharma di Leerink Partners - Martedì, 11 marzo 2025, alle 9:20 AM ET
- La 27ª Conferenza Globale Annuale sulla Salute di Barclays - Mercoledì, 12 marzo 2025, alle 3:30 PM ET
Entrambe le discussioni informali saranno accessibili attraverso la pagina delle Relazioni con gli Investitori sul sito web di Evolus, con le registrazioni disponibili per 90 giorni dopo ogni presentazione.
Evolus (NASDAQ: EOLS), una empresa de belleza de rendimiento enfocada en construir un portafolio estético, ha anunciado su próxima participación en dos importantes conferencias para inversores en Miami, FL.
El equipo de gestión de la empresa participará en charlas informales y reuniones con inversores en:
- La Conferencia Global de Biopharma de Leerink Partners - Martes, 11 de marzo de 2025, a las 9:20 AM ET
- La 27ª Conferencia Anual Global de Salud de Barclays - Miércoles, 12 de marzo de 2025, a las 3:30 PM ET
Ambas charlas informales estarán accesibles a través de la página de Relaciones con Inversores en el sitio web de Evolus, con grabaciones disponibles durante 90 días después de cada presentación.
에볼루스 (NASDAQ: EOLS), 미용 성과 회사로 미적 포트폴리오 구축에 중점을 두고 있는 에볼루스가 플로리다주 마이애미에서 열리는 두 개의 주요 투자자 회의에 참여할 예정이라고 발표했습니다.
회사의 경영진은 파이어사이드 채팅 및 투자자 회의에 참여할 예정입니다:
- 리어링크 파트너스 글로벌 바이오파마 컨퍼런스 - 2025년 3월 11일 화요일, 오전 9:20 ET
- 바클레이스 제27회 글로벌 헬스케어 컨퍼런스 - 2025년 3월 12일 수요일, 오후 3:30 ET
두 개의 파이어사이드 채팅은 에볼루스 웹사이트의 투자자 관계 페이지를 통해 접근할 수 있으며, 각 발표 후 90일 동안 웹캐스트가 제공됩니다.
Evolus (NASDAQ: EOLS), une entreprise de beauté axée sur la performance et la construction d'un portefeuille esthétique, a annoncé sa prochaine participation à deux grandes conférences pour investisseurs à Miami, FL.
L'équipe de direction de l'entreprise participera à des discussions informelles et des réunions avec des investisseurs lors des événements suivants :
- La Conférence Biopharma Mondiale de Leerink Partners - Mardi 11 mars 2025, à 9h20 ET
- La 27ème Conférence Annuelle Mondiale sur la Santé de Barclays - Mercredi 12 mars 2025, à 15h30 ET
Les deux discussions informelles seront accessibles via la page des Relations avec les Investisseurs sur le site Web d'Evolus, avec des webinaires disponibles pendant 90 jours après chaque présentation.
Evolus (NASDAQ: EOLS), ein Unternehmen für Leistungsästhetik, das sich auf den Aufbau eines ästhetischen Portfolios konzentriert, hat seine bevorstehende Teilnahme an zwei wichtigen Investorenkonferenzen in Miami, FL, angekündigt.
Das Management-Team des Unternehmens wird an Feuerplatzgesprächen und Investorenmeetings teilnehmen:
- Die Leerink Partners Global Biopharma Conference - Dienstag, 11. März 2025, um 9:20 Uhr ET
- Die 27. Barclays Global Healthcare Conference - Mittwoch, 12. März 2025, um 15:30 Uhr ET
Beide Feuerplatzgespräche werden über die Investor Relations-Seite der Evolus-Website zugänglich sein, wobei die Webcasts 90 Tage nach jeder Präsentation verfügbar bleiben.
- None.
- None.
- The Leerink Partners Global Biopharma Conference, the fireside chat will take place on Tuesday, March 11, 2025, at 9:20 AM ET.
- The Barclays 27th Annual Global Healthcare Conference, the fireside chat will take place on Wednesday, March 12, 2025, at 3:30 PM ET.
The fireside chats can be accessed on the Investor Relations page of the Evolus website here. A replay of the webcast will be available for 90 days after the date of each presentation.
About Evolus, Inc.
Evolus (NASDAQ: EOLS) is a global performance beauty company redefining the aesthetic injectable market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Our mission is to become a global leader in aesthetics anchored by our flagship products: Jeuveau® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics, and Evolysse™, a collection of unique injectable hyaluronic acid (HA) gels. Visit us at www.evolus.com, and follow us on LinkedIn, X, Instagram or Facebook.
Jeuveau® and Nuceiva®, are registered trademarks and Evolysse™ is a trademark of Evolus, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250227660374/en/
Investors:
Nareg Sagherian, Vice President, Head of Global Investor Relations and Corporate Communications
Phone: (248) 202-9267
Email: ir@evolus.com
Media:
Email: media@evolus.com
Source: Evolus
FAQ
When is Evolus (EOLS) presenting at the Leerink Partners Conference in 2025?
What time is Evolus's (EOLS) fireside chat at the Barclays Healthcare Conference 2025?
How long will Evolus (EOLS) conference webcasts be available for viewing?
Which investor conferences is Evolus (EOLS) attending in March 2025?
